NASDAQ:IBBQ Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News $22.46 -0.04 (-0.18%) (As of 09:30 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends About Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBBQ alerts:Sign Up Key Stats Today's Range$22.46▼$22.4650-Day Range$21.96▼$24.4752-Week Range$20.14▼$24.84Volume1,436 shsAverage Volume18,813 shsMarket Capitalization$36.61 millionAssets Under Management$39.83 millionDividend Yield1.02%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.Read More… Invesco Nasdaq Biotechnology ETF ExpensesTypeIBBQHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.19%0.57%0.55%0.50%0.52%Other Expenses0.00%0.30%0.49%0.41%0.53%Total Expense0.19%0.70%0.71%0.64%0.71%Fee Waiver0.00%-0.45%-0.51%-0.31%-0.56%Net Expense0.19%0.61%0.61%0.57%0.59% Receive IBBQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBBQ ETF News HeadlinesInvesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest UpdateDecember 16 at 3:59 AM | americanbankingnews.comInvesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here's How Some Of Their Peers Have Performed In The Past YearNovember 7, 2024 | msn.comWill the Nasdaq 100 crash?In a world where some top money managers say you should “diversify” with a basket of stocks to help lower risk in your portfolio… And others say you should focus on only one ticker at a time because you can’t really keep detailed tabs on 10, 20 or more stocks at once… My #1 strategy to play the Nasdaq bull run has shown the power to provide the best of BOTH worlds at the same time. Because it harnesses ONE ticker that bottles up all the firepower of Apple, Nvidia, Tesla and more into one place… While I cannot promise future returns or against losses… This strategy targets major payouts OVERNIGHT!December 18, 2024 | DTI (Ad)IBBQ Invesco Nasdaq Biotechnology ETFOctober 21, 2024 | seekingalpha.comUpstream Bio valued at $1.1 bln as shares jump in Nasdaq debutOctober 11, 2024 | reuters.comImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company SymposiumSeptember 16, 2024 | markets.businessinsider.comSee More Headlines IBBQ ETF - Frequently Asked Questions How have IBBQ shares performed this year? Invesco Nasdaq Biotechnology ETF's stock was trading at $21.89 at the beginning of 2024. Since then, IBBQ stock has increased by 2.8% and is now trading at $22.5017. View the best growth stocks for 2024 here. Who are Invesco Nasdaq Biotechnology ETF's major shareholders? Invesco Nasdaq Biotechnology ETF's top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (15.93%) and ORG Partners LLC (0.07%). How do I buy shares of Invesco Nasdaq Biotechnology ETF? Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Invesco Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Nasdaq Biotechnology ETF investors own include Vanguard Total Stock Market ETF (VTI), Verizon Communications (VZ), CrowdStrike (CRWD), DocuSign (DOCU), Meta Platforms (META), NVIDIA (NVDA) and Shopify (SHOP). Fund Details IssuerInvesco Fund NameInvesco Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBQ Inception Date6/11/2021 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Previous SymbolNASDAQ:IBBQ WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings214 Fund Statistics Assets Under Management$39.66 million Average Daily Volume$0.00 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerLatour Trading Options OptionableN/A Short Interest800 shs Miscellaneous Outstanding Shares1,630,000Beta0.61 Creation Unit10,000 Creation Fee$600.00 Get This Free Report Top 10 IBBQ HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 9.69%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 8.07%Amgen (NASDAQ:AMGN)Holding Weight: 7.03%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 5.61%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.09%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.36%Illumina (NASDAQ:ILMN)Holding Weight: 2.41%Biogen (NASDAQ:BIIB)Holding Weight: 2.34%argenx (NASDAQ:ARGX)Holding Weight: 2.02%Moderna (NASDAQ:MRNA)Holding Weight: 1.80%Full Holdings DetailsIBBQ Sector ExposureIBBQ Industry Exposure This page (NASDAQ:IBBQ) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
